Transurethral Water Vapor Ablation: Potential for a Novel Prostate Cancer Management Strategy
Water vapor ablation has low morbidity. It is possible to successfully retreat residual disease or new lesions identified on surveillance with only transient mild to moderate adverse events and acceptable oncologic outcomes offering a new management strategy for localized prostate cancer.
Authors
- Benjamin Spilseth (ORCID: https://orcid.org/0000-0002-8330-3394)
- Christopher A. Warlick (ORCID: https://orcid.org/0000-0002-8697-9015)
- Christopher Dixon (ORCID: https://orcid.org/0000-0002-4411-6297)
Institutions
- University of Minnesota (US)
- Good Samaritan Hospital (US)
Publication Details
- Journal
- Research and Reports in Urology
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/rru.s498872
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00